Coronary artery disease and Helicobacter pylori infection: Should we consider eradication therapy as cardiovascular prevention strategy?

被引：11

作者：

Zuin, Marco ^{[1
,2
]}

Rigatelli, Gianluca ^{[3
]}

Del Favero, Giuseppe ^{[4
]}

Picariello, Claudio ^{[1
]}

Meggiato, Tamara ^{[4
]}

Conte, Luca ^{[1
]}

Faggian, Giuseppe ^{[5
]}

Zuliani, Giovanni ^{[2
]}

Roncon, Loris ^{[1
]}

机构：

[1] Rovigo Gen Hosp, Dept Cardiol, Rovigo, Italy

[2] Univ Ferrara, Sect Internal & Cardiopulm Med, Dept Med Sci, Ferrara, Italy

[3] Rovigo Gen Hosp, Dept Cardiovasc Diag & Endoluminal Intervent, Rovigo, Italy

[4] Rovigo Gen Hosp, Dept Gastroenterol, Rovigo, Italy

[5] Univ Verona, Dept Cardiac Surg, Verona, Italy

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 223卷

关键词：

Coronary artery disease; Helicobacter pylori; Cardiovascular prevention; METAANALYSIS;

D O I：

10.1016/j.ijcard.2016.08.320

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：711 / 712

页数：2

共 50 条

[1] HELICOBACTER PYLORI INFECTION IN CORONARY ARTERY DISEASE
Kowalski, M.
Pawlik, M.
Konturek, J. W.
Konturek, S. J.
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2006, 57 : 101 - 111
[2] Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy
Kountouras, Jannis
Polyzos, Stergios A.
Katsinelos, Panagiotis
Zeglinas, Christos
Artemaki, Fotini
Tzivras, Dimitri
Vardaka, Elizabeth
Gavalas, Emmanouel
Romiopoulos, Iordanis
Simeonidou, Constantina
Grigoriadis, Nikolaos
Kountouras, Constantinos
Dardiotis, Efthimios
Deretzi, Georgia
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 229 : 17 - 18
[3] Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection
Sereni, Giuliana
Azzolini, Francesco
Camellini, Lorenzo
Formisano, Debora
Decembrino, Francesco
Iori, Veronica
Tioli, Cristiana
Cavina, Maurizio
Di Mario, Francesco
Bedogni, Giuliano
Sassatelli, Romano
WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (33) : 4542 - 4548
[4] Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty
Kowalski, M
Konturek, PC
Pieniazek, P
Karczewska, E
Kluczka, A
Grove, R
Kranig, W
Nasseri, R
Thale, J
Hahn, EG
Konturek, SJ
DIGESTIVE AND LIVER DISEASE, 2001, 33 (03): : 222 - 229
[5] Relation of Helicobacter pylori infection and angiographically demonstrated coronary artery disease
Tsai, CJ
Huang, TY
DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (06) : 1227 - 1232
[6] Helicobacter pylori infection and severity of coronary atherosclerosis in patients with chronic coronary artery disease
Jukic, Anita
Bozic, Dorotea
Kardum, Dusko
Becic, Tina
Luksic, Bruno
Vrsalovic, Mislav
Ljubkovic, Marko
Fabijanic, Damir
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 933 - 938
[7] Helicobacter pylori seroprevalence in coronary artery disease
Grozdovska-Naumoska, Mirjana
Kotevski, Vlatko
Trojacanec-Piponska, Sonja
BIOCHEMIA MEDICA, 2007, 17 (02) : 193 - 196
[8] Association of Helicobacter pylori infection with coronary artery disease: is it an independent risk factor?
Riad, Mohamed
EGYPTIAN HEART JOURNAL, 2021, 73 (01)
[9] Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection
Giuliana Sereni
Francesco Azzolini
Lorenzo Camellini
Debora Formisano
Francesco Decembrino
Veronica Iori
Cristiana Tioli
Maurizio Cavina
Francesco Di Mario
Giuliano Bedogni
Romano Sassatelli
World Journal of Gastroenterology, 2012, (33) : 4542 - 4548
[10] Role of Probiotics in Eradication Therapy for Helicobacter pylori Infection
Kamiya, Shigeru
Yonezawa, Hideo
Osaki, Takako
HELICOBACTER PYLORI IN HUMAN DISEASES: ADVANCES IN MICROBIOLOGY, INFECTIOUS DISEASES AND PUBLIC HEALTH. VOL 11, 2019, 1149 : 243 - 255

← 1 2 3 4 5 →